Dong-A Pharmaceutical Launches Water-Free Powder Cold Medicine

Technology|
|
By Park Si-eun
|
Dong-A Pharmaceutical launches 'Panpyrin Time Powder', a water-free powder cold medicine - Seoul Economic Daily Technology News from South Korea
Dong-A Pharmaceutical launches 'Panpyrin Time Powder', a water-free powder cold medicine

Dong-A Pharmaceutical announced on the 4th that it has launched Panpyrin Time Granules, a powder cold medicine that dissolves directly in the mouth without water.

Panpyrin Time Granules is a powder-type cold medicine that can be taken immediately without water anytime and anywhere when cold symptoms appear. It contains active ingredients including acetaminophen, chlorpheniramine, riboflavin, tipepidine, and DL-methylephedrine, which can help relieve major cold symptoms such as runny nose, sore throat, fever, cough, and muscle pain.

The product can be taken with confidence as it contains no added sugar, artificial coloring, caffeine, or preservatives, and includes vitamin B2 to aid recovery from cold symptoms. The new product applies OD!FS (Orally Disintegrating Fast Solution) patented formulation technology, allowing it to dissolve quickly in the mouth with only a small amount of saliva for excellent convenience. The drug features micro-particle structure design with special surface treatment that effectively blocks bitter taste, while added lemon flavor enhances consumer preference. The convenient stick-type powder format is easy to carry and take, suitable for ages 2 and above through elderly patients. Panpyrin Time Granules is an over-the-counter medication available at nearby pharmacies.

A Dong-A Pharmaceutical official said, "Panpyrin Time Granules applies special formulation technology to dissolve quickly in the mouth with minimal bitter taste, making it a cold medicine that can be taken anytime, anywhere," adding, "Panpyrin will expand its lineup of various formulations to provide customized solutions tailored to consumer preferences."

Related Video

AI-translated from Korean. Quotes from foreign sources are based on Korean-language reports and may not reflect exact original wording.